Početna › Okularna hipertenzija › Texas
Kliničke studije za Okularna hipertenzija u državi Texas
8 studija za Okularna hipertenzija traži sudionike na lokacijama u državi Texas.
Gradovi u državi Texas
Službeni tekst studije (engleski)
iDose TR Administration in an Office-Based Surgery Setting
- Glaukos Investigative Site, Austin
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT07816692A Study to Evaluate Efficacy and Safety of YSBP Compared to Lumigan in Patients With Glaucoma or Ocular Hypertension
- Houston Eye Associates, Houston
- R and R eye research, San Antonio
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 23. ruj 2026. · NCT07661329Phase 2 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
- Glaukos Clinical Site, El Paso
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 17. ruj 2026. · NCT07075718Clarifying the Optimal Application of SLT Therapy Trial
- Ophthalmology Associates, Fort Worth
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 14. kol 2026. · NCT04967989Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhone)
- R and R Eye Research, LLC, San Antonio
U tijeku regrutacijaFaza 3
Od 22 godina i više · Oba spola · Ažurirano 20. lis 2025. · NCT07218796Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhine)
- Houston Eye Associates, Houston
U tijeku regrutacijaFaza 3
Od 22 godina i više · Oba spola · Ažurirano 20. lis 2025. · NCT07218783Nanodropper Use in Primary Open-Angle Glaucoma Patients: A Non-Inferiority Trial
- Wilford Hall Ambulatory Surgical Center, Lackland Air Force Base
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 6. svi 2023. · NCT05844384Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.
- Keystone Research, Austin
- Houston Eye Associates, North Loop, Houston
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 10. kol 2022. · NCT05401357Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.